Skip to main content
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: Brain Behav Immun. 2007 Dec 26;22(4):538–543. doi: 10.1016/j.bbi.2007.10.017

Table 1. Group Means and Standard Deviations For Outcome Measures.

Day of Onset Day of Peak Severity Maximum Disease Severity Cumulative Disease Index

Experiment 1

Control (n = 5)
    (No ALA or saccharin) 13.2 (1.1) 14.6 (0.9) 4.6 (1.1) 35.4 (16.3)

ALA 7-16 (n = 7)
    (ALA+saccharin days 7-16 only) 12.6 (6.3) 26.0 (2.2) 4.6 (1.4) 21.4 (8.7)

ALA 7-28 (n = 5)
    (ALA only days 7-28) 17.2 (8.2) 20.2 (5.7) 1.4 (0.9) 4.8 (3.6)

Experiment 2

US+CS:CSo (n = 7)
    (ALA+saccharin days 7-16 only) 27.3 (2.5) 23.9 (2.2) 6.3 (1.5) 43.6 (8.5)

US+CS:CS (n = 7)
    (ALA+saccharin days 7-16, saccharin only days 17-28) 29.3 (2.4) 26.0 (2.5) 4.6 (2.0) 23.9 (13.8)